← FDA Drug Approvals (Drugs@FDA)

CABOMETYX

NDA · New Drug Application · Sponsor: EXELIXIS INC · Approved 2016-04-25

Drug application

FDA Application #

NDA208692

Application type

New Drug Application

Brand name

CABOMETYX

Generic name

CABOZANTINIB

Active ingredients

CABOZANTINIB S-MALATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EXELIXIS INC

Manufacturer

Exelixis, Inc.

First approval

2016-04-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown